NRT Smoking Cessation Aids in Canada

NRT Smoking Cessation Aids in Canada

  • September 2016
  • 24 pages
  • Euromonitor International
Report ID: 149225
NRT smoking cessation aids posted slow current value growth of 2% in 2016, to reach C$159 million. As in the previous year, the decreasing prevalence of tobacco use and the rising desire of smokers to quit, facilitated by a wide range of programmes in Canada, were amongst the growth drivers. NRT smoking cessation aids play an important role in many of these programmes. However, the category is also facing challenges from alternatives, such as prescription smoking cessation products and e-cigaret...

Euromonitor International’s NRT Smoking Cessation Aids in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=Canada Industry=OTC ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=EuromonitorInternational Price=1000